Advances in Animal Modeling in the Study of Bone-Vascular Axis Comorbidities

LI Jiayang, ZHOU Yumeng, LUO Yuwen, HUANG Xuelin, ZHANG Demao, LIU Xiaoheng

Abstract

Osteoporosis and cardiovascular calcification, two major age-related chronic diseases that China is confronting today, pose serious threats to public health. Previous studies have reported overlapping connections in the pathological processes and molecular mechanisms of these two diseases, particularly concerning inflammation, oxidative stress, and dysregulation of mineral metabolism, and that these two diseases tend to share common pathogenic factors. However, research exploring the comorbidity mechanisms of the two diseases remains limited in both depth and scope, largely due to the lack of widely accepted comorbidity animal models. Herein, we analyzed the latest research findings on the comorbidity mechanisms of vascular calcification and osteoporosis, focusing on summarizing the animal disease models currently in extensive use and the relevant evaluation criteria. We aim to provide new references for comorbidity research models and offer scientific evidence for future studies on pathological mechanisms and the development of new therapeutic strategies.

 

 Keywords: Vascular calcification, Osteoporosis, Animal models, Review


Full Text:

PDF


References


Den UYL D, NURMOHAMED M T, Van TUYL L H, et al. (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis. Arthritis Res Ther, 2011, 13(1): R5. doi: 10.1186/ar3224.

ADEJUYIGBE B, KALLINI J, CHIOU D, et al. Osteoporosis: molecular pathology, diagnostics, and therapeutics. Int J Mol Sci, 2023, 24(19): 14583. doi: 10.3390/ijms241914583.

KIEL D P , KAUPPILA L I , CUPPLES L A, et al. Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study. Calcif Tissue Int, 2001, 68(5): 271-276. doi: 10. 1007/BF02390833.

VACHEY C, CANDELLIER A, TOUTAIN S, et al. The bone-vascular axis in chronic kidney disease: from pathophysiology to treatment. Curr Osteoporos Rep, 2024, 22(1): 69-79. doi: 10.1007/s11914-023-00858-8.

ISERI K, QURESHI A R, DAI L, et al. Bone mineral density at different sites and 5 years mortality in end-stage renal disease patients: a cohort study. Bone, 2020, 130: 115075. doi: 10.1016/j.bone.2019.115075.

El-HUSSEINI A, ABDALBARY M, LIMA F, et al. Response to “Low Turnover Bone Disease in Early CKD Stages”. Kidney Int Rep, 2022, 7(6): 1445-1446. doi: 10.1016/j.ekir.2022.04.011.

WEI X, HUANG X, LIU N, et al. Understanding the stony bridge between osteoporosis and vascular calcification: impact of the FGF23/Klotho axis. Oxid Med Cell Longev, 2021, 2021: 7536614. doi: 10.1155/2021/7536614.

HOFBAUER L C, BRUECK C C, SHANAHAN C M, et al. Vascular calcification and osteoporosis—from clinical observation towards molecular understanding. Osteoporos Int, 2006, 18(3): 251-259. doi: 10. 1007/s00198-006-0282-z.

BELLONE F, CINQUEGRANI M, NICOTERA R, et al. Role of vitamin K in chronic kidney disease: a focus on bone and cardiovascular health. Int J Mol Sci, 2022, 23(9): 5282. doi: 10.3390/ijms23095282.

AASETH J O, FINNES T E, ASKIM M, et al. The importance of vitamin K and the combination of vitamins K and D for calcium metabolism and bone health: a review. Nutrients, 2024, 16(15): 2420. doi: 10.3390/nu16152420.

TANRIOVER C, COPUR S, MUTLU A, et al. Early aging and premature vascular aging in chronic kidney disease. Clin Kidney J, 2023, 16(11): 1751-1765. doi: 10.1093/ckj/sfad076.

PICKERING M E. Cross-talks between the cardiovascular disease-sarcopenia-osteoporosis triad and magnesium in humans. Int J Mol Sci, 2021, 22(16): 9102. doi: 10.3390/ijms22169102.

CANNATA-ANDÍA J B, CARRILLO-LÓPEZ N, MESSINA O D, et al. Pathophysiology of vascular calcification and bone loss: Linked disorders of ageing? Nutrients, 2021, 13(11): 3835. doi: 10.3390/nu13113835.

SUTTON N R, MALHOTRA R, St HILAIRE C, et al. Molecular mechanisms of vascular health: insights from vascular aging and calcification. Arterioscler Thromb Vasc Biol, 2023, 43(1): 15-29. doi: 10. 1161/atvbaha.122.317332.

EVENEPOEL P, OPDEBEECK B, DAVID K, et al. Bone-vascular axis in chronic kidney disease. Adv Chronic Kidney Dis, 2019, 26(6): 472-483. doi: 10.1053/j.ackd.2019.09.006.

DEMER L L, TINTUT Y. The leading edge of vascular calcification. Trends Cardiovasc Med, 2015, 25(4): 275-277. doi: 10.1016/j.tcm.2014.11.010. FERNÁNDEZ-VILLABRILLE S, MARTÍN-CARRO B, MARTÍN-VÍRGALA J, et al. Novel biomarkers of bone metabolism. Nutrients, 2024, 16(5): 605. doi: 10.3390/nu16050605.

RINOTAS V, GKIKOPOULOU E, TZORTZIS E, et al. Interplay between bone marrow adiposity and bone resorption in RANKL‐mediated modelled osteoporosis. J Cell Physiol, 2024, 239(12): e31434. doi: 10.1002/jcp.31434.

RIBEIRO M S P, VENTURINI L G R, SPECK-HERNANDEZ C A, et al. AMPKα1 negatively regulates osteoclastogenesis and mitigates pathological bone loss. J Biol Chem, 2023, 299(12): 105379. doi: 10.1016/j. jbc.2023.105379.

WANG Z X, LUO Z W, LI F X, et al. Aged bone matrix-derived extracellular vesicles as a messenger for calcification paradox. Nat Commun, 2022, 13(1): 1453. doi: 10.1038/s41467-022-29191-x.

KEUM B R, KIM H J, L E E J, et al. Heterogeneous osteoimmune profiles via single-cell transcriptomics in osteoporotic patients who fail bisphosphonate treatment. Proc Natl Acad Sci U S A, 2024, 121(8): e2316871121. doi: 10.1073/pnas.2316871121.


Refbacks

  • There are currently no refbacks.